Reference health

In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery

https://doi.org/10.1007/s12253-019-00773-3
CiteStamped reference-health badge
71/71 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 71 checked references that resolve
resolves10.1002/med.20238
Targeted Drug Delivery and Penetration Into Solid Tumors
resolves10.2174/138920111796117373
Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
resolves10.3762/bjoc.14.64
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
resolves10.1155/2012/967347
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
resolves10.1177/107327480200900207
Future of Monoclonal Antibodies in the Treatment of Hematologic Malignancies
resolves10.1038/nbt1320
Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting
resolves10.3390/pharmaceutics10040223
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
resolves10.1002/ijc.2910540122
Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation
resolves10.1182/blood-2008-04-150862
The neovasculature homing motif NGR: more than meets the eye
resolves10.1126/science.279.5349.377
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
resolves10.1038/nm0195-27
Angiogenesis in cancer, vascular, rheumatoid and other disease
resolves10.1016/S0092-8674(00)80108-7
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
resolves10.1038/nrc905
Clinical translation of angiogenesis inhibitors
resolves10.1038/s41388-018-0213-4
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
resolves10.1016/0268-960X(92)90020-Q
The significance of aminopeptidases and haematopoietic cell differentiation
resolves10.2174/092986707780059571
The Structure and Main Functions of Aminopeptidase N
resolves10.1016/S0167-5699(98)01398-X
CD13—not just a marker in leukemia typing
resolves10.1136/jcp.47.1.43
Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin.
resolves10.1016/j.molmed.2008.06.003
The moonlighting enzyme CD13: old and new functions to target
resolves10.1182/blood.V97.3.652
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
resolves10.1073/pnas.0611653104
Impaired angiogenesis in aminopeptidase N-null mice
resolves10.1016/j.canlet.2005.11.051
Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis
resolves10.1053/gast.2002.31095
Aminopeptidase N is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer
resolves10.1096/fasebj.7.2.8440407
Aminopeptidases: structure and function
resolves10.1117/1.2839046
In vivo optical imaging of CD13/APN-expression in tumor xenografts
resolves10.1002/cncr.21149
Addition of an aminopeptidase N‐binding sequence to human endostatin improves inhibition of ovarian carcinoma growth
resolves10.1161/01.ATV.0000245807.65714.0b
cNGR: A Novel Homing Sequence for CD13/APN Targeted Molecular Imaging of Murine Cardiac Angiogenesis In Vivo
resolves10.1089/104303404322959524
Inhibition of Tumor Growth by Intramuscular Injection of cDNA Encoding Tumor Necrosis Factor <i>α</i> Coupled to NGR and RGD Tumor-Homing Peptides
resolves10.1182/blood-2008-04-150318
Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience
resolves10.1158/0008-5472.CAN-08-0689
Quantitative Molecular Magnetic Resonance Imaging of Tumor Angiogenesis Using cNGR-Labeled Paramagnetic Quantum Dots
resolves10.1371/journal.pone.0178632
NGR-peptide−drug conjugates with dual targeting properties
resolves10.1038/81183
Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
resolves10.1038/12469
Anti-cancer activity of targeted pro-apoptotic peptides
resolves10.1158/0008-5472.CAN-06-2117
Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
resolves10.1021/bc070031k
Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
resolves10.1021/bc900065r
Peptide Targeting of Platinum Anti-Cancer Drugs
resolves10.1039/b417734g
Synthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil
resolves10.3390/ijms18020429
Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain
resolves10.1007/BF01024992
Formation of isoaspartate 99 in bovine and porcine somatotropins
resolves10.1111/j.1399-3011.1986.tb03231.x
Deamidation of the asparaginyl‐glycyl sequence
resolves10.1016/S0021-9258(19)75855-4
Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.
resolves10.1073/pnas.082102799
Protein deamidation
resolves10.1016/j.jconrel.2009.12.031
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
resolves10.1021/jm501630j
Development of Cyclic NGR Peptides with Thioether Linkage: Structure and Dynamics Determining Deamidation and Bioactivity
resolves10.1074/jbc.M109.044297
Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching
resolves10.1074/jbc.M710273200
Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin
resolves10.1002/anie.201004363
Conformational Control of Integrin‐Subtype Selectivity in <i>iso</i>DGR Peptide Motifs: A Biological Switch
resolves10.3762/bjoc.14.78
Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
resolves10.1242/bio.2012364
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
resolves10.1111/j.1365-2133.2000.03709.x
Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature
resolves10.1016/S0959-8049(01)00121-6
Biology of Kaposi's sarcoma
resolves10.1016/j.tcb.2013.04.001
Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming
resolves10.1097/00002030-199706000-00003
The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposiʼs sarcoma-derived cells and a new immortalized Kaposiʼs sarcoma cell line
resolves10.1007/BF01756387
Expression and role of integrins in adhesion of human colonic carcinoma cells to extracellular matrix components
resolves10.1128/JVI.01673-07
Integrin α <sub>V</sub> β <sub>3</sub> Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor
resolves10.1016/S1359-6101(97)00037-3
Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
resolves10.1128/JVI.01334-09
Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells
resolves10.1182/blood.V84.8.2711.2711
Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls [see comments]
resolves10.1158/1535-7163.MCT-08-0600
Monoclonal antibody 14C5 targets integrin αvβ5
resolves10.1002/anie.201007091
Use of Metadynamics in the Design of isoDGR‐Based αvβ3 Antagonists To Fine‐Tune the Conformational Ensemble
resolves10.1007/s00726-010-0766-1
In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites
resolves10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
The Ki-67 protein: From the known and the unknown
resolves10.1016/S0065-230X(08)60946-X
Tumor Angiogenesis
resolves10.3748/wjg.v21.i41.11854
Animal models of human colorectal cancer: Current status, uses and limitations
resolves10.1007/s10637-016-0354-7
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice
resolves10.1016/j.ejmech.2019.05.016
Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems
resolves10.3390/ijms20194763
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
resolves10.21769/BioProtoc.2311
Intracaecal Orthotopic Colorectal Cancer Xenograft Mouse Model
resolves10.4103/0976-500X.81895
Toxicological screening
resolves10.1016/S0753-3322(05)80082-4
Natural killer cells in breast cancer cell growth and metastasis in SCID mice
The 10 references without a DOI — listed, not checked
no DOI — not checkedWang RE, Niu Y, Wu H, Amin MN, Cai J (2011) Development of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol Imaging 1(1):36–46
no DOI — not checkedMenrad A, Speicher D, Wacker J, Herlyn M (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53(6):1450–1455
no DOI — not checkedChen H, Kinzer CA, Paul WE (1996) p161, a murine membrane protein expressed on mast cells and some macrophages, is mouse CD13/aminopeptidase N. J Immunol Baltim Md 157(6):2593–2600
no DOI — not checkedDrexler HG (1987) Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. Leukemia 1(10):697–705
no DOI — not checkedMáté G, Kertész I, Enyedi KN et al (2015) In vivo imaging of aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR). Eur J Pharm Sci Off J Eur Fed Pharm Sci 69:61–71
no DOI — not checkedCorti A (2004) Strategies for improving the anti-neoplastic activity of TNF by tumor targeting. Methods Mol Med 98:247–264
no DOI — not checkedCorti A, Curnis F, Rossoni G, Marcucci F, Gregorc V (2013) Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example. BioDrugs Clin Immunother Biopharm Gene Ther 27(6):591–603
no DOI — not checkedMingozzi M, Dal Corso A, Marchini M et al (2013) Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands. Chem Weinh Bergstr Ger 19(11):3563–3567
no DOI — not checkedKuntzman R, Mark LC, Brand LC et al (1966) Metabolism of drugs and carcinogens by human liver enzymes. J Pharmacol Exp Ther 152(1):151–156
no DOI — not checkedHirst DG, Denekamp J (1979) Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 12(1):31–42
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1007/s12253-019-00773-3"><img src="https://citestamp.com/citestamped/10.1007/s12253-019-00773-3/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1007/s12253-019-00773-3/badge.svg)](https://citestamp.com/citestamped/10.1007/s12253-019-00773-3)